Ezra M. Friedberg - 25 Nov 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Role
Director
Signature
/s/ Ezra M. Friedberg
Issuer symbol
CHRO
Transactions as of
25 Nov 2025
Net transactions value
-$280,280
Form type
4
Filing time
26 Nov 2025, 12:37:02 UTC
Previous filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Friedberg Ezra M Director C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Ezra M. Friedberg 26 Nov 2025 0001679440

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTHS Common Stock Sale $167,972 -5,999 -15% $28.00 34,001 25 Nov 2025 By Balmoral Financial Group LLC F1
transaction PTHS Common Stock Sale $56,270 -2,000 -5.9% $28.14 32,001 25 Nov 2025 By Balmoral Financial Group LLC F1
transaction PTHS Common Stock Sale $28.5 -1 -0% $28.50 32,000 25 Nov 2025 By Balmoral Financial Group LLC F1
transaction PTHS Common Stock Sale $56,010 -2,000 -6.2% $28.00 30,000 25 Nov 2025 By Balmoral Financial Group LLC F1
holding PTHS Common Stock 40,000 25 Nov 2025 By Key Recovery Group LLC F1
holding PTHS Common Stock 54,573 25 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.